Olivia Knowles, a 33-year-old from Blackpool, underwent a seismic shift in her life when she received a devastating diagnosis of acute myeloid leukaemia (AML) after initially being informed that her symptoms were likely due to long Covid. What began as headaches and fatigue in late 2023 spiralled into a whirlwind of treatments, relapses, and unimaginable news. Olivia’s journey took a turn for the worse in early 2025 when she was given the heart-wrenching prognosis of having just months to live. Amidst the turmoil, the option of assisted dying was broached, a suggestion Olivia steadfastly opposed as she resolved to continue her fight against the disease.
From undergoing gruelling rounds of chemotherapy to enduring the emotional rollercoaster of hopeful remission and crushing relapse, Olivia’s resilience shines through. Her determination to raise funds for AML research at King’s College Hospital saw her pushing her physical limits by embarking on a 20-mile walk, despite the toll the disease had taken on her body. The funds she raised underscore her commitment to supporting advancements in AML treatment, highlighting the urgent need for progress in combating this challenging condition.
Olivia’s battle with cancer unfolded unexpectedly, starting with subtle signs during a sporting event in Finland and culminating in a diagnosis that upended her world. The journey of misdiagnosis and subsequent revelation of the aggressive AML serves as a poignant reminder of the complex nature of medical conditions and the importance of timely and accurate diagnoses. Olivia’s unwavering spirit in the face of setbacks epitomises courage in adversity, inspiring those around her to rally behind her cause and strive for breakthroughs in AML treatment.
Despite setbacks and the recurrence of the disease following a period of hope post-transplant, Olivia’s resolve remains unshaken as she explores innovative treatment options and considers participating in clinical trials. Her openness about her journey, including the emotional toll and physical challenges, sheds light on the multifaceted impact of battling a life-threatening illness. Olivia’s candour about her desires for normalcy, such as returning to work and engaging in everyday routines, underscores the profound impact that illness can have on one’s sense of identity and purpose.
The support and generosity shown towards Olivia’s fundraising efforts reflect a broader community coming together to support those facing daunting health challenges. The outpouring of donations and well-wishes encapsulates the power of collective compassion in driving research and advancements in medical care. Olivia’s unwavering dedication to making a difference through her fundraising initiatives serves as a beacon of hope for those navigating similar journeys and emphasises the importance of solidarity in facing adversity.
As Olivia forges ahead in her battle against AML, her resilience and determination stand as a testament to the human spirit’s capacity to persevere in the face of unimaginable odds. Her willingness to share her story and advocate for research into AML amplifies the urgency of addressing gaps in treatment options and fostering innovation in cancer care. Olivia’s journey is a poignant reminder of the fragility of life, the strength found in community support, and the unwavering resilience that can emerge in the most challenging of circumstances.